Drug class
Amebicides, Systemic
Systemic amebicides, also referred to as tissue amebicides, are antiparasitic agents that achieve high systemic drug concentrations to eradicate invasive protozoan parasites in vascularized tissues outside or deep within the intestinal mucosa. Read more about Amebicides, Systemic
9 drugs in this class 9 manufacturers
Drugs in Amebicides, Systemic
PAROMOMYCIN SULFATE
SOLOSEC (secnidazole)
HUMATIN (paromomycin sulfate)
TINIDAZOLE
SOLOSEC (secnidazole)
SOLOSEC (secnidazole)
TINIDAZOLE
PAROMOMYCIN SULFATE
Systemic amebicides, also referred to as tissue amebicides, are antiparasitic agents that achieve high systemic drug concentrations to eradicate invasive protozoan parasites in vascularized tissues outside or deep within the intestinal mucosa.
Depending on the specific agent, they act through cytotoxic mechanisms such as generating reactive nitro radical intermediates that disrupt parasitic DNA, or by accumulating in host tissues to inhibit parasitic cellular processes.
Clinically, these agents are primarily indicated for invasive intestinal amebiasis and extraintestinal disease caused by *Entamoeba histolytica*, most notably amebic liver abscesses.
Standard clinical practice couples systemic treatment with a luminal amebicide to ensure the complete elimination of persisting colonization within the bowel lumen.
-
nih.gov
Systemic amebicides, also referred to as tissue amebicides, are antiparasitic agents that achieve high systemic drug concentrations to eradicate invasive protozoan parasites in vascularized tissues outside or deep within the intestinal mucosa Clinically, these agents are primarily indicated for invasive intestinal amebiasis and extraintestinal disease caused by *Entamoeba histolytica*, most notably amebic liver abscesses Standard clinical practice couples systemic treatment with a luminal amebic...
-
nih.gov
Systemic amebicides, also referred to as tissue amebicides, are antiparasitic agents that achieve high systemic drug concentrations to eradicate invasive protozoan parasites in vascularized tissues outside or deep within the intestinal mucosa Clinically, these agents are primarily indicated for invasive intestinal amebiasis and extraintestinal disease caused by *Entamoeba histolytica*, most notably amebic liver abscesses
-
fda.gov
Depending on the specific agent, they act through cytotoxic mechanisms such as generating reactive nitro radical intermediates that disrupt parasitic DNA, or by accumulating in host tissues to inhibit parasitic cellular processes
-
scribd.com
Depending on the specific agent, they act through cytotoxic mechanisms such as generating reactive nitro radical intermediates that disrupt parasitic DNA, or by accumulating in host tissues to inhibit parasitic cellular processes
-
nih.gov
Standard clinical practice couples systemic treatment with a luminal amebicide to ensure the complete elimination of persisting colonization within the bowel lumen
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.